Showing results (281-290 of 26,110) with videos related to
Sort By:
Pageof 2,611
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2018
Chronic Neutrophilic Leukemia: Current and Future PerspectivesSangeetha Venugopal, John MascarenhasBlood|April 11, 2013
A comprehensive review and analysis of the effect of ruxolitinib therapy on the survival of patients with myelofibrosisJohn Mascarenhas, Ronald HoffmanCurrent Opinion in Hematology|December 25, 2013
Pathogenesis and management of acute myeloid leukemia that has evolved from a myeloproliferative neoplasmRaajit Rampal, John MascarenhasHuman Reproduction (Oxford, England)|August 1, 1993
Severe ovarian hyperstimulation syndrome, selective embryo reduction and heterotopic pregnancyL Mascarenhas, B EliotBiophysical Journal|November 1, 1977
Thermal-stimulated pressure and current studies of bound water in lysozymeS Celaschi, S MascarenhasLeukemia & Lymphoma|December 8, 2025
Interferon alpha in myeloproliferative neoplasms: evidence and practical considerations for clinical careMegan Metzger, John MascarenhasMethods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Measurement of chemosensitivity and growth rate in p53 expressing cellsMahesh Ramamoorthy, Catherine Vaughan, Sumitra Deb, et al.Indian Journal of Experimental Biology|October 28, 2014
In vitro culture of immature embryos of Cinnamomum tamala Nees.--the role of different factorsMadhabi S Deb, N S Jamir, Chitta Ranjan DebIEEE Transactions on Systems, Man, and Cybernetics. Part B, Cybernetics : a Publication of the IEEE Systems, Man, and Cybernetics Society|October 12, 2007
Generating compact classifier systems using a simple artificial immune systemKevin Leung, France Cheong, Christopher CheongInternational Journal of Oncology|February 17, 2001
The human oncoprotein MDM2 uses distinct strategies to inhibit transcriptional activation mediated by the wild-type p53 and its tumor-derived mutantsD R Brown, D Deb, R Frum, et al.Pageof 2,611